Amanote Research
Register
Sign In
The Revised Who Classification of Myelodysplastic Syndromes – What Has Changed?
Pathology
- United States
doi 10.1016/j.pathol.2020.01.142
Full Text
Open PDF
Abstract
Available in
full text
Categories
Forensic Medicine
Pathology
Date
February 1, 2020
Authors
Gina Zini
Publisher
Elsevier BV
Related search
The Revised Who Classification of Myeloproliferative Neoplasms – What Has Changed?
Pathology
Forensic Medicine
Pathology
Validation of and Proposals for Refinements of the WHO 2016 Classification for Myelodysplastic Syndromes
American Journal of Hematology
Hematology
Erratum To: Rheumatoid Arthritis: What Has Changed?
Skeletal Radiology
Nuclear Medicine
Radiology
Imaging
The Myelodysplastic Syndromes
Emerging Cancer Therapeutics
The Myelodysplastic Syndromes
Oncologist
Cancer Research
Medicine
Oncology
Fuelwood Revisited: What Has Changed in the Last Decade?
What Has Changed in the Structure of Revision Hip Arthroplasty?
Traumatology and Orthopedics of Russia
Myelodysplastic Syndromes
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Myelodysplastic Syndromes
Cancer
Cancer Research
Oncology